AIM Dana dhuwit perusahaan AIM ImmunoTech

AIM ImmunoTech, Inc. - logo grafis emiten AIM

The erosion of market advantage due to delays in the commercialization of Ampligen is weighing on margins for AIM ImmunoTech (AIM). The company's cash position on the GURU.Markets system summary chart reflects liquidity dynamics, where the 0.01 level captures the current state. Potential is based on the development of RNA cancer drugs, while success relies on government grants and clinical trial results to scale production.

Dhuwit awis perusahaan: AIM ImmunoTech, Inc. (AIM) kanggo 04.07.2022 - 21.11.2026

AIM ImmunoTech, Inc. (AIM) - rincian metrik lan laporan keuangan

Analisis kabeh metrik perusahaan:AIM ImmunoTech AIM
Produk mawa merek AIM ImmunoTech Inc.

The scale of AIM ImmunoTech operations is clearly reflected in the company's cash position. This indicator captures the daily liquidity balance, eliminating the time lags associated with quarterly reports. This calculation allows for the real-time tracking of the burn rate and the risk of cash flow gaps. For a developer of immunomodulators, such transparency is critical, as business success depends on drug approval cycles. A stable reserve guarantees the sustainability of research regardless of macroeconomic fluctuations.

Pesaing wigati

Volume dana dhuwit perusahaan ARGX|BioNTech - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan ABVX (abivax.com)|Sisa dhuwit perusahaan ADMA|Protagonist Therapeutics, Inc. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Immunovant, Inc.|KNSA: Volume dana dhuwit perusahaan|GRFS - Aset likuid perusahaan|ADPT (Adaptive Biotechnologies Inc.) - Volume dana dhuwit perusahaan|CLDX: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Aurinia Pharmaceuticals Inc. (AUPH)|Dana dhuwit perusahaan BCRX (BioCryst Pharmaceuticals Inc)|Volume dana dhuwit perusahaan VERA (Vera Corp)|Gunggung dana dhuwit perusahaan DNTH (Dianthus Therapeutics)|PHVS - Dana dhuwit perusahaan|ABCL: Dana dhuwit perusahaan|TRML: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Precigen, Inc.|Dhuwit awis perusahaan PHAR|Nektar Therapeutics - Total volume dana dhuwit perusahaan|Dana dhuwit perusahaan Upstream Bio Corp (UPB)|Dhuwit awis perusahaan Zenas Biopharma ZBIO|Dana dhuwit perusahaan Immunome Bio IMNM|GOSS: Dhuwit awis lan setara dhuwit awis perusahaan|kalvista.com - Volume dana dhuwit perusahaan|SEPN (septerna.com) - Dhuwit awis lan setara dhuwit awis perusahaan|PVLA (Pieris Pharmaceuticals) - Dhuwit awis perusahaan|Savara - Sisa dhuwit perusahaan|RIGL (Rigel Corp) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan AnaptysBio Corp|Dana dhuwit perusahaan astriatx.com (ATXS)|Dhuwit awis perusahaan enGene ENGN|Dana dhuwit perusahaan RAPT Therapeutics, Inc. RAPT|JBIO - Dhuwit awis perusahaan|Aclaris Therapeutics Inc. - Volume dana dhuwit perusahaan|KYTX - Volume dana dhuwit perusahaan|TLSA (Tiziana Life Sciences PLC) - Dhuwit awis perusahaan|cabalettabio.com (CABA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Ventyx Biosciences|THTX (Theratechnologies) - Gunggung dana dhuwit perusahaan|Dhuwit awis perusahaan AVTX (Avalo Therapeutics Inc.)|Dana dhuwit perusahaan ELDN (Eledon)|Volume dana dhuwit perusahaan AGEN (Agenus, Inc)|Aset likuid perusahaan climbbio.com (CLYM)|zurabio.com - Volume dana dhuwit perusahaan|ATYR - Volume dana dhuwit perusahaan|ADAG: Volume dana dhuwit perusahaan|Ikena Oncology, Inc. (IMA) - Volume dana dhuwit perusahaan|STTK (Shattuck Therapeutics) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan equilliumbio.com EQ|Volume dana dhuwit perusahaan CNTB|IMUX - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Atara Biotherapeutics ATRA|Aset likuid perusahaan InflaRx N.V. (IFRX)|XFOR: Dhuwit awis perusahaan|adicetbio.com (ACET) - Dhuwit awis perusahaan|CELU: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan INmune Bio (INMB)|Dana dhuwit perusahaan Barinthus Bio|Dhuwit awis lan setara dhuwit awis perusahaan KZR (Kezar Life Sciences, Inc)|Dhuwit awis perusahaan SABS (SAB Biotherapeutics Inc)|Akari Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|Enlivex Therapeutics Ltd - Dhuwit awis perusahaan|Sisa dhuwit perusahaan QTTB|GOVX - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Edesa|IBIO: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Carisma Therapeutics Inc (CARM)|Dana dhuwit perusahaan XTL Biopharmaceuticals, Ltd.|Dana dhuwit perusahaan BOLT|Dhuwit awis perusahaan HCWB (HCW Biologics, Inc.)|Gunggung dana dhuwit perusahaan APVO|Aditxt - Dhuwit awis perusahaan|Posisi dhuwit perusahaan gribio.com|XRTX: Dhuwit awis perusahaan|Sisa dhuwit perusahaan HIND (Vyome Holdings)|REVB (Revelation Bio) - Dhuwit awis perusahaan|Indaptus Corp (INDP) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan scinai.com|Dhuwit awis perusahaan CalciMedica, Inc. (CALI)|Dana dhuwit perusahaan Affimed NV (AFMD)|Dana dhuwit perusahaan ALLK (Allakos Inc)|Dana dhuwit perusahaan HOOKIPA Pharma, Inc. HOOK|Aset likuid perusahaan IGM Bio (IGMS)|iTeos Pharma - Volume dana dhuwit perusahaan|Aset likuid perusahaan oceanbiomedical.com OCEA|TC BioPharm (TCBP) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan THRD